Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients.

Maiter D, Bex M, Vroonen L, T'Sjoen G, Gil T, Banh C, Chadarevian R.

Ann Endocrinol (Paris). 2016 Apr 7. pii: S0003-4266(16)00027-5. doi: 10.1016/j.ando.2016.02.005. [Epub ahead of print]

PMID:
27063476
2.

Pituitary tumors contain a side population with tumor stem cell-associated characteristics.

Mertens F, Gremeaux L, Chen J, Fu Q, Willems C, Roose H, Govaere O, Roskams T, Cristina C, Becú-Villalobos D, Jorissen M, Poorten VV, Bex M, van Loon J, Vankelecom H.

Endocr Relat Cancer. 2015 Aug;22(4):481-504. doi: 10.1530/ERC-14-0546. Epub 2015 Apr 28.

PMID:
25921430
3.

Retention of [(18)F]fluoride on reversed phase HPLC columns.

Ory D, Van den Brande J, de Groot T, Serdons K, Bex M, Declercq L, Cleeren F, Ooms M, Van Laere K, Verbruggen A, Bormans G.

J Pharm Biomed Anal. 2015;111:209-14. doi: 10.1016/j.jpba.2015.04.009. Epub 2015 Apr 9.

PMID:
25898315
4.

Epididymal adrenal rest tissue in a patient with congenital adrenal hyperplasia.

Bonne L, Bex M, Oyen R, Claus F.

JBR-BTR. 2014 May-Jun;97(3):193-4. No abstract available.

PMID:
25223140
5.

Giant prolactinomas in women.

Delgrange E, Raverot G, Bex M, Burman P, Decoudier B, Devuyst F, Feldt-Rasmussen U, Andersen M, Maiter D.

Eur J Endocrinol. 2013 Nov 22;170(1):31-8. doi: 10.1530/EJE-13-0503. Print 2014 Jan. Review.

6.

Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.

Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D.

Pituitary. 2014 Feb;17(1):81-9. doi: 10.1007/s11102-013-0471-7.

PMID:
23446424
7.

Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly.

Verhelst J, Velkeniers B, Maiter D, Haentjens P, T'Sjoen G, Rietzschel E, Corvilain B, Abrams P, Nobels F, Abs R, Bex M.

Eur J Endocrinol. 2013 Jan 17;168(2):177-84. doi: 10.1530/EJE-12-0753. Print 2013 Feb.

8.

Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.

Pilaete K, Delaere P, Decallonne B, Bex M, Hauben E, Nuyts S, Clement P, Hermans R, Vander Poorten V.

B-ENT. 2012;8(2):113-21.

PMID:
22896930
9.

Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.

Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Pérez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacchè M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SP, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PL.

JAMA. 2010 Dec 15;304(23):2611-9. doi: 10.1001/jama.2010.1830.

PMID:
21156949
10.

A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.

Hannan FM, Nesbit MA, Christie PT, Lissens W, Van der Schueren B, Bex M, Bouillon R, Thakker RV.

Clin Endocrinol (Oxf). 2010 Dec;73(6):715-22. doi: 10.1111/j.1365-2265.2010.03870.x.

PMID:
20846291
11.

Paroxysmal nonkinesigenic dyskinesias due to recurrent hypoglycemia caused by an insulinoma.

Debruyne F, Van Paesschen W, Van Eyken P, Bex M, Vandenberghe W.

Mov Disord. 2009 Feb 15;24(3):460-1. doi: 10.1002/mds.22386. No abstract available.

PMID:
19235926
12.

GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets.

Freson K, Izzi B, Labarque V, Van Helvoirt M, Thys C, Wittevrongel C, Bex M, Bouillon R, Godefroid N, Proesmans W, de Zegher F, Jaeken J, Van Geet C.

J Clin Endocrinol Metab. 2008 Dec;93(12):4851-9. doi: 10.1210/jc.2008-0883. Epub 2008 Sep 23.

PMID:
18812479
13.

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.

Wolter P, Stefan C, Decallonne B, Dumez H, Bex M, Carmeliet P, Schöffski P.

Br J Cancer. 2008 Aug 5;99(3):448-54. doi: 10.1038/sj.bjc.6604497.

14.

Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly.

Alexopoulou O, Bex M, Abs R, T'Sjoen G, Velkeniers B, Maiter D.

J Clin Endocrinol Metab. 2008 Apr;93(4):1324-30. doi: 10.1210/jc.2007-2104. Epub 2008 Jan 29.

PMID:
18230660
15.

Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.

Chitneni SK, Garreau L, Cleynhens B, Evens N, Bex M, Vermaelen P, Chalon S, Busson R, Guilloteau D, Van Laere K, Verbruggen A, Bormans G.

Nucl Med Biol. 2008 Jan;35(1):75-82. Epub 2007 Nov 19.

PMID:
18158946
16.

Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines? - Results of a national survey.

Van den Bruel A, Moreno-Reyes R, Bex M, Daumerie C, Glinoer D.

Clin Endocrinol (Oxf). 2008 Apr;68(4):599-604. Epub 2007 Nov 6.

PMID:
17986280
17.

Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.

T'Sjoen G, Bex M, Maiter D, Velkeniers B, Abs R.

Eur J Endocrinol. 2007 Oct;157(4):411-7.

18.

AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects.

Bex M, Abs R, T'Sjoen G, Mockel J, Velkeniers B, Muermans K, Maiter D.

Eur J Endocrinol. 2007 Oct;157(4):399-409.

19.

[Hoffmann syndrome presenting to the emergency department].

Kaux JF, Castermans C, Delmotte P, Bex M.

Ann Readapt Med Phys. 2007 Jun;50(5):310-2. Epub 2007 Feb 20. French.

PMID:
17434641
20.

Levothyroxine replacement therapy after thyroid surgery.

Verhaert N, Vander Poorten V, Delaere P, Bex M, Debruyne F.

B-ENT. 2006;2(3):129-33.

PMID:
17067083
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk